Combinostics
Using a combination of science and AI technology and aims to improve the lives of patients with neurological disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
€16—24m (Dealroom.co estimates Nov 2019.)
Company register number 2631684-7
Tampere Pirkanmaa (HQ)
Financials
Estimates*
| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | <1m | <1m | <1m | <1m | <1m | 1.1m | 2.0m |
| % growth | 100 % | 109 % | 29 % | 185 % | 13 % | 37 % | - |
| EBITDA | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) | - |
| % EBITDA margin | (626 %) | (245 %) | (163 %) | (14 %) | (69 %) | (71 %) | - |
| Profit | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) | - |
| % profit margin | (638 %) | (275 %) | (188 %) | (35 %) | (85 %) | (75 %) | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
* | N/A | Spinout | |
| N/A | €350k | Seed | |
€320k | Seed | ||
* | €670k | Seed | |
| N/A | N/A | Seed | |
N/A | Grant | ||
$4.3m | Series A | ||
| Total Funding | €5.3m | ||
Recent News about Combinostics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.